IL6 and acute respiratory distress syndrome: In this study, intravenous exosome administration outperformed intranasal and nebulized routes in reducing histopathological injury scores and pro-inflammatory cytokine levels (TNF-α, IL-6, IL-1β) in LPS-induced ALI mice.